ACE2 and COVID-19: Moreover, the molecular docking results showed that the main active compounds in AE combine with SARS-COV-2 3CL pro and ACE2 with a lower binding energy, which also suggests that AE with multiple components have a potential therapeutic effect on COVID-19.